ZILBRYSQ Trademark

Trademark Overview


On Thursday, September 14, 2023, a trademark application was filed for ZILBRYSQ with the United States Patent and Trademark Office. The USPTO has given the ZILBRYSQ trademark a serial number of 98179729. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2025. This trademark is owned by Ra Pharmaceuticals, Inc.. The ZILBRYSQ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis

Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
zilbrysq

General Information


Serial Number98179729
Word MarkZILBRYSQ
Filing DateThursday, September 14, 2023
Status700 - REGISTERED
Status DateTuesday, January 28, 2025
Registration Number7673264
Registration DateTuesday, January 28, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis
Goods and ServicesSyringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 3, 2023
Primary Code005
First Use Anywhere DateWednesday, January 3, 2024
First Use In Commerce DateWednesday, January 3, 2024

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, October 3, 2023
Primary Code010
First Use Anywhere DateWednesday, January 3, 2024
First Use In Commerce DateWednesday, January 3, 2024

Trademark Owner History


Party NameUCB HOLDINGS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSMYRNA, GA 30080

Party NameRa Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameRa Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameRa Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Monday, September 18, 2023NEW APPLICATION ENTERED
Tuesday, April 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 8, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, April 30, 2024ASSIGNED TO LIE
Tuesday, April 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 8, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024ASSIGNED TO EXAMINER
Wednesday, May 8, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2024USE AMENDMENT FILED
Tuesday, August 27, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, October 29, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 14, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 14, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, November 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 6, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 6, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 28, 2025REGISTERED-PRINCIPAL REGISTER
Monday, February 24, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 28, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED